학술논문

U.S. Food and Drug Administration approval: Vismodegib for recurrent, locally advanced, or metastatic basal cell carcinoma
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 1 May 2013, 19(9):2289-2293)
Subject
Language
English
ISSN
10780432
15573265